|
PELI2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62569957495862E-12 |
| Normal-vs-Stage2 |
1.01859964907192E-10 |
| Normal-vs-Stage3 |
1.6207035713478E-11 |
| Normal-vs-Stage4 |
4.18710000005262E-08 |
| Stage1-vs-Stage2 |
8.793000E-01 |
| Stage1-vs-Stage3 |
7.144800E-01 |
| Stage1-vs-Stage4 |
8.805000E-01 |
| Stage2-vs-Stage3 |
8.739000E-01 |
| Stage2-vs-Stage4 |
9.673600E-01 |
| Stage3-vs-Stage4 |
9.298200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6885381981524E-12 |
| Normal-vs-AfricanAmerican |
<1E-12 |
| Normal-vs-Asian |
1.07989999997837E-06 |
| Caucasian-vs-AfricanAmerican |
4.259300E-03 |
| Caucasian-vs-Asian |
4.648000E-01 |
| AfricanAmerican-vs-Asian |
9.033800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
3.40310002400201E-11 |
| Male-vs-Female |
2.009000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.19589893543548E-11 |
| Normal-vs-Extreme_Weight |
4.66293670342566E-15 |
| Normal-vs-Obese |
7.08988423525625E-13 |
| Normal-vs-Extreme_Obese |
7.92800003424077E-09 |
| Normal_Weight-vs-Extreme_Weight |
8.853200E-01 |
| Normal_Weight-vs-Obese |
2.779800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.072800E-01 |
| Extreme_Weight-vs-Obese |
2.822200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.367000E-01 |
| Obese-vs-Extreme_Obese |
2.538800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.96850005582417E-10 |
| Normal-vs-Age(41-60Yrs) |
2.01505478969466E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
4.500799954954E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.127600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.288200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.216800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.297700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.117400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.601000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63702384980979E-12 |
| Normal-VS-Type2 PRCC |
<1E-12 |
| Normal-VS-KIRP CIMP |
3.1627000000034E-06 |
| Normal-VS-Unclassified PRCC |
6.88680223959182E-11 |
| Type1 PRCC-VS-Type2 PRCC |
3.722200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.035400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.090600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.075400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.889000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.063800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
2.36750000000008E-05 |
| Normal-vs-N2 |
1.00219999998874E-06 |
| N0-vs-N1 |
7.284200E-02 |
| N0-vs-N2 |
3.649400E-01 |
| N1-vs-N2 |
1.800160E-01 |
|
|
